Organization · Venture Capital
Borealis Ventures
Borealis Ventures is a Hanover, New Hampshire-based venture capital firm that invests in early-stage healthcare and life sciences companies across the United States, leveraging a strong network from Dartmouth College.
Overview
What Borealis Ventures does
What Borealis Ventures is
Borealis Ventures is a Hanover, New Hampshire-based venture capital firm that invests in early-stage healthcare and life sciences companies across the United States, leveraging a strong network from Dartmouth College.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2002
- Approximate age
- About 24 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find Borealis Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Borealis Ventures as a funder
Investment thesis
Borealis Ventures backs entrepreneurs transforming healthcare through new therapies, digital innovation, and technology, leveraging a strong network from Dartmouth University.
Focus narrative
Borealis Ventures invests in life science platforms, digital health, and animal health. The firm operates as lifecycle investors and collaborates with syndicate partners to provide comprehensive resources to their portfolio companies.
Value beyond capital
Borealis Ventures provides comprehensive resources to its portfolio companies, leveraging its strong network and expertise in healthcare to support entrepreneurs in building transformative businesses.
Terms and economics
- Typical check
- $250,000–$750,000
Focus and fit
- Stages
- Seed · Series A
- Regions
- CanadaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 40
- Recorded notable exits
- Glaukos, Repligen, Merck, CMPX, and CVET
Portfolio context
Borealis Ventures has backed a range of companies in the healthcare sector, including notable exits such as companies acquired by Glaukos, Repligen, and Merck, as well as those that have gone public like NASDAQ: CMPX and NASDAQ: CVET.
Common questions
What to know about Borealis Ventures
Upseed classifies Borealis Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.